KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Debt Ratio: 2020-2025

Historic Debt Ratio for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Sep 2025 value amounting to 0.01.

  • Recursion Pharmaceuticals' Debt Ratio fell 62.38% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 62.38%. This contributed to the annual value of 0.02 for FY2024, which is 984.57% up from last year.
  • According to the latest figures from Q3 2025, Recursion Pharmaceuticals' Debt Ratio is 0.01, which was down 15.57% from 0.02 recorded in Q2 2025.
  • Recursion Pharmaceuticals' Debt Ratio's 5-year high stood at 0.04 during Q2 2024, with a 5-year trough of 0.00 in Q4 2022.
  • Its 3-year average for Debt Ratio is 0.01, with a median of 0.01 in 2025.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 97.82% in 2022, then skyrocketed by 2,208.58% in 2024.
  • Quarterly analysis of 5 years shows Recursion Pharmaceuticals' Debt Ratio stood at 0.00 in 2021, then declined by 26.30% to 0.00 in 2022, then soared by 128.57% to 0.00 in 2023, then spiked by 984.57% to 0.02 in 2024, then slumped by 62.38% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.02 for Q2 2025, and 0.02 during Q1 2025.